Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on PQQ Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108191858B reveals a novel PQQ intermediate route avoiding CAN oxidant. Delivers cost reduction in pharmaceutical intermediates manufacturing and high-purity output.